﻿{"id":322,"date":"2008-08-01T00:00:01","date_gmt":"2008-08-01T00:00:01","guid":{"rendered":"https:\/\/awge.doctime.es\/?p=322"},"modified":"2016-05-24T08:22:23","modified_gmt":"2016-05-24T06:22:23","slug":"awge-127","status":"publish","type":"post","link":"https:\/\/awge.doctime.es\/index.php\/2008\/08\/01\/awge-127\/","title":{"rendered":"Pre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial"},"content":{"rendered":"<div class='editorialPost'><strong>Editorial:  J Bone Joint Surg B<\/strong><\/div>\n<div class='fechaPost'>Fecha: 01\/08\/2008<\/div>\n<div class='autorPost'>Moonen AF, Thomassen BJ, Knoors NT, van Os JJ, Verburg AD, Pilot P<\/div>\n<div class='enlacePost'><a href='http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18669967?ordinalpos=1&#038;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum' target='_blank'>Acceso al enlace publicador<\/a><\/div>\n<hr>\n<\/hr>\n<div class='resumenPost'>This prospective randomised clinical trial evaluated the effect of alternatives for allogeneic blood transfusions after total hip replacement and total knee replacement in patients with pre-operative haemoglobin levels between 10.0 g\/dl and 13.0 g\/dl. A total of 100 patients were randomly allocated to the Eprex (pre-operative injections of epoetin) or Bellovac groups (post-operative retransfusion of shed blood). Allogeneic blood transfusions were administered according to hospital policy. In the Eprex group, 4% of the patients (two patients) received at least one allogeneic blood transfusion. In the Bellovac group, where a mean 216 ml (0 to 700) shed blood was retransfused, 28% (14 patients) required the allogeneic transfusion (p = 0.002). When comparing Eprex with Bellovac in total hip replacement, the percentages were 7% (two of 30 patients) and 30% (nine of 30 patients) (p = 0.047) respectively, whereas in total knee replacement, the percentages were 0% (0 of 20 patients) and 25% (five of 20 patients) respectively (p = 0.042). Pre-operative epoetin injections are more effective but more costly in reducing the need for allogeneic blood transfusions in mildly anaemic patients than post-operative retransfusion of autologous blood.\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Editorial: J Bone Joint Surg B Fecha: 01\/08\/2008 Moonen AF, Thomassen BJ, Knoors NT, van Os JJ, Verburg AD, Pilot<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[],"_links":{"self":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/322"}],"collection":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/comments?post=322"}],"version-history":[{"count":1,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/322\/revisions"}],"predecessor-version":[{"id":743,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/322\/revisions\/743"}],"wp:attachment":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/media?parent=322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/categories?post=322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/tags?post=322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}